Caregiver Burden Associated with Injectable On-Demand Treatment of Hereditary Angioedema Attacks in Children

Kalvista Pharmaceuticals Inc. published this content on May 22, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 28, 2026 at 17:22 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]